MARKET

NLSP

NLSP

Nls Pharmaceutics Ltd
NASDAQ
1.650
-0.050
-2.94%
Closed 16:41 05/08 EDT
OPEN
1.740
PREV CLOSE
1.700
HIGH
1.750
LOW
1.650
VOLUME
30.33K
TURNOVER
67.68M
52 WEEK HIGH
18.39
52 WEEK LOW
1.300
MARKET CAP
5.94M
P/E (TTM)
-0.2456
1D
5D
1M
3M
1Y
5Y
1D
NLS Pharmaceutics Extends Merger Agreement with Kadimastem
TipRanks · 3d ago
Weekly Report: what happened at NLSP last week (0428-0502)?
Weekly Report · 4d ago
NLS Pharmaceutics Delays Yearly Report Filing
TipRanks · 05/01 14:19
Weekly Report: what happened at NLSP last week (0421-0425)?
Weekly Report · 04/28 09:57
NLS Pharmaceutics Announces Board Resignation Amid Restructuring Efforts
TipRanks · 04/24 20:28
Weekly Report: what happened at NLSP last week (0414-0418)?
Weekly Report · 04/21 09:57
NLS Pharmaceutics Reports Positive Results in Fentanyl Study
TipRanks · 04/15 13:27
NLS Pharmaceutics Says Results From Study KO-943 Provides Evidence That Mazindol May Offer Non-Opioid Approach For Treatment Of Fentanyl Use Disorder
Benzinga · 04/15 13:06
More
About NLSP
NLS Pharmaceutics AG, formerly NLS 1 Pharma AG, is a Switzerland-based company that operates as a biopharmaceutical company. The Company focuses on development of medicines for neurobehavioral and neurocognitive disorders treatment. The Company serves customers worldwide.
Recently
Symbol
Price
%Change

Webull offers NLS Pharmaceutics AG stock information, including NASDAQ: NLSP real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, NLSP stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading NLSP stock methods without spending real money on the virtual paper trading platform.